Effect of Prosopis Ointment in Dermatitis

Phase 2

• Conditions: Atopic Dermatitis.; Atopic dermatitis, unspecified; L20.9

• Registration Number: IRCT20190220042770N1
• Lead Sponsor: Yazd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Patients with Typical lesions of Mild to Moderate Atopic Dermatitis

Exclusion Criteria

Patients with Psoriasis
Sensitivity to Ointment
Concurrent Bacterial infection or Systemic disease (except Asthma and Allergic Rhinitis)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Eczema area and Severity index. Timepoint: Before starting treatment and ending weeks 1 and 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.

Secondary Outcome Measures

Name	Time	Method
Erythema. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.;Tickness. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.;Scratching or Excoriation. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.;Lichenification. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.